|
|
|
|
|
|
|
|
|
|
"Since increased clusterin production is observed in many human cancers, including prostate, non-small cell lung, breast, ovarian, bladder, renal, pancreatic, anaplastic large cell lymphoma and colon cancers and melanoma, OGX-011 may have broad market potential to treat many cancer indications and disease stages."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.